Home » BioCryst Begins Phase II Study for Treatment of Seasonal Influenza
BioCryst Begins Phase II Study for Treatment of Seasonal Influenza
BioCryst Pharmaceuticals announced the initiation of a Phase II study of intramuscular (i.m.) peramivir for the treatment of seasonal influenza.
Fox Business
Fox Business
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May